13 employees
Holobiome is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems.
2015
$1M
from 1 investors over 1 rounds
Holobiome raised $1M on October 28, 2021
Investors: Corundum Systems Biology